BioSig Technologies, Inc. (BSGM) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
55 GREENS FARMS ROAD WESTPORT, CT 06880 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3,727 | 142 | 615 | 2,104 | 416 | 200 | |||
| Cash and cash equivalent | 3,727 | 142 | 615 | 2,104 | 416 | 200 | |||
| Receivables | 109 | 109 | 81 | 54 | 14 | 24 | |||
| Inventory, net of allowances, customer advances and progress billings | (1,976) | ||||||||
| Inventory | (1,976) | ||||||||
| Prepaid expense | 150 | 80 | 113 | 163 | 220 | 206 | |||
| Other undisclosed current assets | 13 | 39 | 65 | 90 | 2,074 | ||||
| Total current assets: | 3,986 | 344 | 848 | 2,386 | 740 | 528 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 55 | 96 | 137 | 257 | 335 | 412 | |||
| Property, plant and equipment | 68 | 85 | 111 | 137 | 182 | 509 | |||
| Intangible assets, net (including goodwill), including: | 265 | 270 | 274 | 279 | 285 | 289 | |||
| Goodwill | |||||||||
| Intangible assets, net (excluding goodwill) | 265 | 270 | 274 | 279 | 285 | 289 | |||
| Other undisclosed intangible assets, net (including goodwill) | |||||||||
| Other noncurrent assets | 44 | 44 | 44 | 44 | |||||
| Other undisclosed noncurrent assets | 3 | 4 | 48 | 47 | 16 | ||||
| Total noncurrent assets: | 432 | 498 | 570 | 721 | 849 | 1,270 | |||
| TOTAL ASSETS: | 4,418 | 842 | 1,418 | 3,107 | 1,589 | 1,798 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,507 | 2,052 | 1,448 | 2,604 | 4,821 | 4,116 | |||
| Accrued liabilities | 529 | 700 | 500 | 1,676 | 2,717 | 2,312 | |||
| Other undisclosed accounts payable and accrued liabilities | 978 | 1,352 | 948 | 928 | 2,104 | 1,804 | |||
| Deferred revenue | 16 | ||||||||
| Derivative instruments and hedges, liabilities | |||||||||
| Other undisclosed current liabilities | 172 | 212 | 253 | 372 | 411 | 450 | |||
| Total current liabilities: | 1,679 | 2,264 | 1,701 | 2,976 | 5,232 | 4,582 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 15 | 60 | 103 | ||||||
| Operating lease, liability | 15 | 60 | 103 | ||||||
| Other undisclosed noncurrent liabilities | 500 | ||||||||
| Total noncurrent liabilities: | 15 | 560 | 103 | ||||||
| Total liabilities: | 1,679 | 2,264 | 1,701 | 2,991 | 5,792 | 4,685 | |||
| Temporary equity, including noncontrolling interest | 105 | 105 | 105 | 105 | 105 | 105 | |||
| Equity | |||||||||
| Equity, attributable to parent | 2,605 | (1,544) | (405) | (6) | (4,321) | (3,018) | |||
| Common stock | 24 | 17 | 17 | 15 | 11 | 9 | |||
| Additional paid in capital | 260,738 | 253,784 | 253,824 | 252,311 | 244,085 | 241,988 | |||
| Accumulated other comprehensive income | |||||||||
| Accumulated deficit | (258,157) | (255,345) | (254,246) | (252,332) | (248,417) | (245,015) | |||
| Equity, attributable to noncontrolling interest | 29 | 17 | 17 | 17 | 13 | 26 | |||
| Total equity: | 2,634 | (1,527) | (388) | 11 | (4,308) | (2,992) | |||
| TOTAL LIABILITIES AND EQUITY: | 4,418 | 842 | 1,418 | 3,107 | 1,589 | 1,798 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 17 | 13 | 13 | 14 | 12 | |||
| Sales-type lease, revenue | 17 | |||||||
| Cost of revenue (Cost of Product and Service Sold) | (669) | |||||||
| Other undisclosed gross profit | 669 | |||||||
| Gross profit: | 17 | 13 | 13 | 14 | 12 | |||
| Operating expenses | (2,984) | (1,196) | (2,950) | (5,305) | (3,451) | (6,179) | ||
| Other undisclosed operating loss | (17) | |||||||
| Operating loss: | (2,984) | (1,183) | (2,950) | (5,292) | (3,437) | (6,167) | ||
| Nonoperating income (expense) | 184 | (15) | 15 | (2) | 25 | 38 | ||
| Other nonoperating income (expense) | (15) | (15) | 15 | (2) | 25 | 38 | ||
| Loss from continuing operations before equity method investments, income taxes: | (2,800) | (1,198) | (2,935) | (5,294) | (3,412) | (6,129) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 99 | 1,021 | 1,383 | (3) | 1 | |||
| Net loss: | (2,800) | (1,099) | (1,914) | (3,911) | (3,415) | (6,128) | ||
| Net income (loss) attributable to noncontrolling interest | (12) | (4) | 13 | 79 | ||||
| Net loss attributable to parent: | (2,812) | (1,099) | (1,914) | (3,915) | (3,402) | (6,049) | ||
| Preferred stock dividends and other adjustments | (17) | (24) | (133) | |||||
| Other undisclosed net loss available to common stockholders, basic | (2) | (2) | (2) | (3) | (2) | (2) | ||
| Net loss available to common stockholders, diluted: | (2,814) | (1,118) | (1,940) | (3,918) | (3,537) | (6,051) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (2,800) | (1,099) | (1,914) | (3,911) | (3,415) | (6,128) | ||
| Other undisclosed comprehensive income | ||||||||
| Comprehensive loss: | (2,800) | (1,099) | (1,914) | (3,911) | (3,415) | (6,128) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (12) | (4) | 13 | 79 | ||||
| Comprehensive loss, net of tax, attributable to parent: | (2,812) | (1,099) | (1,914) | (3,915) | (3,402) | (6,049) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.